Literature DB >> 18701033

Severe cutaneous adverse drug reactions: a review on epidemiology, etiology, clinical manifestation and pathogenesis.

Tomy Martin1, Hui Li.   

Abstract

PURPOSE: To review the current progress in epidemiology, etiology, clinical manifestation, and pathophysiology of severe cutaneous adverse drug reactions (SCADRs). DATA SOURCES: Data were acquired by using Blackwell-Synergy, PubMed, original articles published in the main Chinese journals and related medical textbooks materials. Study selection and data extraction Throughout the literature review 49 articles were selected.
RESULTS: SCADRs cases are rare, however, the implication is life threatening with significant mortality rates. Epidemiology studies have shown various incidences from different regions, gender, age, race and concurrent illness. There are typical signs and symptoms for each type of SCADRs, but this is not always so. Drugs associated with inducing SCADRs are anticonvulsants, antibiotics, NSAIDs and antirheumatic drugs. In some countries, especially in Asia, traditional drugs are often the cause of SCADRs. Genetic polymorphisms and viral infections are predisposition factors of SCADRs. Patients with certain genetic alleles and underlying diseases are vulnerable to SCADRs. The exact pathogenesis of SCADRs is not well defined. Nonetheless, recent study showed that reactive metabolites and immunological processes have a significant role in SCADRs.
CONCLUSIONS: The different SCADRs reactions are attributed by different intrinsic factors, such as genetic polymorphisms, gender, age and race as well as extrinsic factors, such as underlying diseases. Different regions and culprit drugs also play a role in the various types of SCADRs.

Entities:  

Mesh:

Year:  2008        PMID: 18701033

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  7 in total

Review 1.  [Triggers of exanthematous drug eruptions: Stop intake, treat through or desensitization?]

Authors:  M Absmaier; T Biedermann; K Brockow
Journal:  Hautarzt       Date:  2017-01       Impact factor: 0.751

2.  Carbamzepine-induced toxic epidermal necrolysis.

Authors:  Nithyananda K Chowta; Mukta N Chowta; John Ramapuram; Pramod Kumar; Abul Fazil
Journal:  Indian J Crit Care Med       Date:  2011-04

Review 3.  Genetic Determinants in HLA and Cytochrome P450 Genes in the Risk of Aromatic Antiepileptic-Induced Severe Cutaneous Adverse Reactions.

Authors:  Ali Fadhel Ahmed; Chonlaphat Sukasem; Majeed Arsheed Sabbah; Nur Fadhlina Musa; Dzul Azri Mohamed Noor; Nur Aizati Athirah Daud
Journal:  J Pers Med       Date:  2021-05-07

4.  Skin rash on site of application of Dashanga Lepa (polyherbal formulation): A rare and unexpected drug reaction.

Authors:  Manjunath Ajanal; Avinash Kadam; Shradda U Nayak
Journal:  Anc Sci Life       Date:  2012-01

5.  Cutaneous adverse drug reactions in a tertiary care teaching hospital: A North Indian perspective.

Authors:  Ruchika Nandha; Anita Gupta; Arif Hashmi
Journal:  Int J Appl Basic Med Res       Date:  2011-01

6.  Stevens-Johnson syndrome and toxic epidermal necrolysis in Dr. Hasan Sadikin General Hospital Bandung, Indonesia from 2009-2013.

Authors:  Oki Suwarsa; Wulan Yuwita; Hartati Purbo Dharmadji; Endang Sutedja
Journal:  Asia Pac Allergy       Date:  2016-01-27

7.  Severe cutaneous adverse drug reactions manifesting as Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in Nigeria: a database review from 2004 to 2017.

Authors:  Kazeem Adeola Oshikoya; Ibrahim Abayomi Ogunyinka; Comfort Kunak Ogar; Abiodun Abiola; Ali Ibrahim; Ibrahim Adekunle Oreagba
Journal:  Ther Adv Drug Saf       Date:  2020-02-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.